MNPR logo

MNPRMonopar Therapeutics Inc

$59.10
$0.325
(0.55%)
Today
Closed $59.10
$0.005
(0.01%)
After Hours
Updated: 06:28 PM EDT
Reported EarningsMay 14
Mkt Cap$398.06M
Vol79,074.00

About

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
22

Frequently Asked Questions

What is Market Cap of Monopar Therapeutics Inc?
What is the 52-week high for Monopar Therapeutics Inc?
What is the 52-week low for Monopar Therapeutics Inc?
What is Monopar Therapeutics Inc stock price today?
What was Monopar Therapeutics Inc stock price yesterday?
What is the PE ratio of Monopar Therapeutics Inc?
What is the Price-to-Book ratio of Monopar Therapeutics Inc?
What is the 50-day moving average of Monopar Therapeutics Inc?
How many employees does Monopar Therapeutics Inc have?

Advertisement|Remove ads.